Intellective Biologics (Suzhou) Co., Ltd.
PrivateLast Round
Series C
Extension
Jan 20, 2023
Est. Valuation
$873M
Total Funding Raised
$112M
Company Overview
Intellective Biologics (Suzhou) Co., Ltd. is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) providing one-stop services from process development to commercial manufacturing for biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Clinical Trials, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intellective Biologics (Suzhou) Co., Ltd. Comparables
Compare Intellective Biologics (Suzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WuXi Biologics | 85% | |
| Innovent Biologics | 80% | |
| GenScript | 80% |
Intellective Biologics (Suzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jan 20, 2023 | ||||
| Series C | Aug 4, 2022 | ||||
| Series B Extension | Sep 1, 2021 | ||||
| Series B | Jun 28, 2021 | ||||
| Series A Extension | May 7, 2021 | ||||
Series A | Nov 1, 2020 |
Intellective Biologics (Suzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B, Series A, Series B Extension |
| Qingsong Fund | Series A, Series B Extension |
| Legend Capital | Series B, Series A, Series B Extension |
| Gaorong Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2022
$74M round led by Gaorong Capital
- Sep 1, 2021
Raised capital from BioTrack Capital, Legend Capital, and Qingsong Fund.
Intellective Biologics (Suzhou) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Intellective Biologics (Suzhou) Co., Ltd.'s valuation, stock price, and market status.
Is Intellective Biologics (Suzhou) Co., Ltd. a public or private company?
Intellective Biologics (Suzhou) Co., Ltd. is a private company.
What is the current stock price of Intellective Biologics (Suzhou) Co., Ltd.?
Intellective Biologics (Suzhou) Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Intellective Biologics (Suzhou) Co., Ltd. worth (valuation)?
Valuation information for Intellective Biologics (Suzhou) Co., Ltd. is not publicly available.
Can I buy Intellective Biologics (Suzhou) Co., Ltd. stock?
Intellective Biologics (Suzhou) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Intellective Biologics (Suzhou) Co., Ltd.'s last funding round?
Funding round information for Intellective Biologics (Suzhou) Co., Ltd. is not publicly available.
Who are the main investors in Intellective Biologics (Suzhou) Co., Ltd.?
Investor information for Intellective Biologics (Suzhou) Co., Ltd. is not publicly disclosed.
Will Intellective Biologics (Suzhou) Co., Ltd. IPO soon?
No public IPO plans have been announced for Intellective Biologics (Suzhou) Co., Ltd..
How can I track Intellective Biologics (Suzhou) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Intellective Biologics (Suzhou) Co., Ltd.'s secondary market activity and sign up for updates.